Trials in progress - A phase I study of loncastuximab tesirine and rituximab following stereotactic radiosurgery in patients with primary and secondary central nervous system lymphomas (SOLAR)
Authors
Thomas A. Ollila (ORCID: https://orcid.org/0000-0003-0102-6491)
Kelsey Baron
Harsh Shah (ORCID: https://orcid.org/0000-0001-6054-5238)
Joe Sammy Mendez (ORCID: https://orcid.org/0000-0002-9138-8658)
Boyu Hu (ORCID: https://orcid.org/0000-0001-9848-9497)
Joshua Palmer
Donald M. Cannon (ORCID: https://orcid.org/0000-0001-7512-3767)
Amit Maity (ORCID: https://orcid.org/0000-0001-7151-2845)
Allison Marie Bock (ORCID: https://orcid.org/0000-0002-3174-8877)
Trials in progress - A phase I study of loncastuximab tesirine and rituximab following stereotactic radiosurgery in patients with primary and secondary central nervous system lymphomas (SOLAR)
Thomas A. Ollila, Kelsey Baron, Harsh Shah, Joe Sammy Mendez et al.
Journal
Blood
Topics
CNS Lymphoma Diagnosis and Treatment
article
Trials in progress - A phase I study of loncastuximab tesirine and rituximab following stereotactic radiosurgery in patients with primary and secondary central nervous system lymphomas (SOLAR)
Thomas A. Ollila, Kelsey Baron, Harsh Shah, Joe Sammy Mendez, Boyu Hu, Joshua Palmer, Donald M. Cannon, Amit Maity, Allison Marie Bock, Yizhe Xu, Lindsey A. Fitzgerald, Daniel A. Ermann, Iyad Alnahhas, Lindsay Burt, Narendranath Epperla
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
Thomas Jefferson University (US), University of Utah (US), Brown University (US), Huntsman Cancer Institute (US), Ohio University (US), KidsOhio (US)